Fintel on MSN23h
Cantor Fitzgerald Initiates Coverage of Acrivon Therapeutics (ACRV) with Overweight Recommendation
Fintel reports that on January 31, 2025, Cantor Fitzgerald initiated coverage of Acrivon Therapeutics (NasdaqGM:ACRV) with a Overweight recommendation. Analyst Price Forecast Suggests 260.44% Upside ...
Hosted on MSN2h
Trump's Greenland ambitions fuel debate over rare minerals
Donald Trump sees Greenland as key to U.S. security, reports "The New York Times," citing its sources. According to "NYT," ...
Ethics Pledges by Trump Cabinet Draw Questions and Skepticism
Publicly released agreements show the vast wealth of President Trump’s cabinet picks and the uncharacteristically large list ...
Lam Research Corporation (LRCX): Positioned for Growth in Wafer Fabrication and Advanced Packaging
We recently published a list of 10 AI News and Ratings Investors Should Take a Look At. In this article, we are going to take a look at where Lam Research Corporation (NASDAQ:LRCX) stands against ...
MercadoLibre (NASDAQ:MELI) Upgraded at New Street Research
MercadoLibre (NASDAQ:MELI – Get Free Report) was upgraded by investment analysts at New Street Research from a “neutral” ...
NVIDIA Co. (NASDAQ:NVDA) Shares Bought by Oak Thistle LLC
Oak Thistle LLC increased its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 267.5% during the 4th quarter, according to ...